High‐volume polyethylene glycol (PEG) solutions are associated with low patient compliance, whereas low‐volume alternatives pose higher risks of adverse events. We compared a new 0.8‐L PEG–ascorbic acid solution containing simethicone… Click to show full abstract
High‐volume polyethylene glycol (PEG) solutions are associated with low patient compliance, whereas low‐volume alternatives pose higher risks of adverse events. We compared a new 0.8‐L PEG–ascorbic acid solution containing simethicone to a 2‐L PEG–ascorbic acid solution.
               
Click one of the above tabs to view related content.